| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.048 | 0.4 |